Endometriosis interview series

We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with “The Endometriosis interview series”. We aim to highlight important aspects of Endometriosis directly from the top exponents! 

As a precision medicine company, Scailyte is dedicated to discovering clinically relevant biomarkers for diagnostics, prognostics, and treatment, starting from single-cell data sets in clinical data sets.

ScaiVision, our proprietary machine learning algorithm platform,  has been used for various biomarker discovery projects in collaboration with clinical, academic, and biotech partners, in different fields, including endometriosis.

We believe that precision medicine has the potential to transform the way endometriosis is diagnosed and treated, and we’re committed to driving progress in this field. Join us in celebrating Endometriosis Awareness Month and stay tuned for our upcoming interviews with leaders in the field.